Democrats’ Toothless Drug Pricing Alternative Is A Coup For Big Pharma
Under the Build Back Better Act, Congress can expand and strengthen Medicare and Medicaid, improving the lives of millions of seniors while also throwing a lifeline to folks living in states where GOP politicians are strangling public benefits.
But to win these popular reforms, we have to defeat the efforts of Big Pharma, their greedy lobbyists and the politicians who take their money.
It wasn’t enough for Democratic Representatives Kurt Schrader of Oregon, Scott Peters of California, Kathleen Rice of New York and Stephanie Murphy of Florida to vote against a robust bill that would allow Medicare to negotiate drug prices, the Lower Drug Costs Now Act (H.R. 3).